Bjornson B H, Harvey J M, Rose L
J Clin Invest. 1985 Sep;76(3):924-9. doi: 10.1172/JCI112091.
Glucocorticosteroid therapy results in an increase in the number of circulating neutrophils and a decrease in the number of eosinophils. Utilizing the double layer soft agar technique, we examined the effect of physiologic to pharmacologic concentrations of hydrocortisone on the proliferation of human neutrophil progenitors and eosinophil progenitors from peripheral blood and bone marrow. When peripheral blood cultures were studied, eosinophil proliferation was inhibited in a dose-responsive fashion with 10(-8) - 10(-5) M hydrocortisone succinate, and comprised 49 +/- 4% of the colonies in control cultures and only 4 +/- 1% (P less than 0.01) at pharmacologic levels of hydrocortisone (10(-5) M). The number of neutrophil colonies, on the other hand, increased by 31% when 10(-5) M hydrocortisone was added to cultures. In order for corticosteroids to exert this effect, it was necessary to add them within 24 h of the initiation of culture. The effect of hydrocortisone on granulocyte proliferation could not be blocked by progesterone, a structurally analogous steroid. To determine whether hydrocortisone was acting directly on the progenitor cell or via an effector cell, its effect on modulating cell populations and stimulating-factor production was studied. Removal of E-rosetting cells and/or adherent cells did not affect the inhibition of eosinophil colony growth or the enhancement of neutrophil colony growth. Furthermore, addition of the potent inhibitor of T cell function, cyclosporin A, failed to affect eosinophil colony frequency, suggesting that inhibition of T cell function was an unlikely explanation for the observed hydrocortisone effect. Leukocyte conditioned media (LCM), derived from peripheral blood mononuclear cells incubated with hydrocortisone, was devoid of both neutrophil and eosinophil colony-stimulating activity, whereas a control LCM stimulated both neutrophil and eosinophil proliferation. The data suggest that the observed hydrocortisone effect on granulocyte colony formation is unlikely to be mediated by an intermediary, and that hydrocortisone acts directly on progenitor cells.
糖皮质激素治疗会导致循环中性粒细胞数量增加,嗜酸性粒细胞数量减少。利用双层软琼脂技术,我们研究了生理浓度至药理浓度的氢化可的松对外周血和骨髓中人类中性粒细胞祖细胞和嗜酸性粒细胞祖细胞增殖的影响。在研究外周血培养物时,嗜酸性粒细胞增殖受到抑制,呈剂量反应关系,10(-8) - 10(-5) M的氢化可的松琥珀酸盐可使嗜酸性粒细胞增殖受到抑制,在对照培养物中嗜酸性粒细胞集落占49±4%,而在药理水平的氢化可的松(10(-5) M)作用下仅占4±1%(P<0.01)。另一方面,当向培养物中添加10(-5) M氢化可的松时,中性粒细胞集落数量增加了31%。为使皮质类固醇发挥这种作用,必须在培养开始后24小时内添加。氢化可的松对粒细胞增殖的作用不能被结构类似的类固醇孕酮所阻断。为了确定氢化可的松是直接作用于祖细胞还是通过效应细胞起作用,研究了其对调节细胞群体和刺激因子产生的影响。去除E花环形成细胞和/或贴壁细胞并不影响嗜酸性粒细胞集落生长的抑制或中性粒细胞集落生长的增强。此外,添加强效T细胞功能抑制剂环孢素A未能影响嗜酸性粒细胞集落频率,这表明T细胞功能的抑制不太可能是观察到的氢化可的松效应的原因。来自与氢化可的松孵育的外周血单个核细胞的白细胞条件培养基(LCM)既没有中性粒细胞也没有嗜酸性粒细胞集落刺激活性,而对照LCM则刺激中性粒细胞和嗜酸性粒细胞增殖。数据表明,观察到的氢化可的松对粒细胞集落形成的作用不太可能由中间介质介导,氢化可的松直接作用于祖细胞。